Clicky

Cellid Co. Ltd(299660)

Description: Cellid, Inc. develops immunothetherapeutic vaccines for cancer and/or infectious diseases therapies. It is developing BVAC-C for cervical, head and neck, anal, and genital cancer with human papilloma virus antigen; BVAC-B for gastric, ovarian, lung, and pancreatic cancer with HER-2/neu antigen; and BVAC-P for prostate, urinary tract, and brain cancer with PAP/PSMA antigens. The company is also developing BVAC-M for cancers, such as melanoma with GP100/MAGE-A3 antigens; and BVAC-Neo, a customized immunotherapeutic vaccine. Cellid, Inc. was founded in 2006 and is based in Seoul, South Korea.


Keywords: Cancer Infectious Diseases Oncology Prostate Cancer Melanoma Pancreatic Cancer Brain Cancer Histopathology Epidemiology Causes Of Death Neo

Home Page: www.cellid.co.kr

Building 142, Korea Seoul National University
Seoul, 08826
South Korea
Phone: 82 2 3285 7861


Exchange: KQ

Country: KR

Currency: Korean Won (₩)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 0
IPO Date:
Fiscal Year End: December
Full Time Employees: 0
Back to stocks